Milestones of Lynch syndrome: 1895–2015

HT Lynch, CL Snyder, TG Shaw, CD Heinen… - Nature Reviews …, 2015 - nature.com
Lynch syndrome, which is now recognized as the most common hereditary colorectal cancer
condition, is characterized by the predisposition to a spectrum of cancers, primarily …

[HTML][HTML] Hereditary colorectal cancer

HT Lynch, A De la Chapelle - New England Journal of Medicine, 2003 - Mass Medical Soc
Colorectal cancers among patients with a familial risk of this disorder account for
approximately one of five cases of this disease. Many cases can be prevented by the …

Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications

HT Lynch, PM Lynch, SJ Lanspa, CL Snyder… - Clinical …, 2009 - Wiley Online Library
More than one million patients will manifest colorectal cancer (CRC) this year of which,
conservatively, approximately 3%(∼ 30,700 cases) will have Lynch syndrome (LS), the most …

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

A Umar, CR Boland, JP Terdiman… - Journal of the …, 2004 - academic.oup.com
Hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch syndrome, is a
common autosomal dominant syndrome characterized by early age at onset, neoplastic …

[HTML][HTML] Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer

FS Leach, NC Nicolaides, N Papadopoulos, B Liu… - Cell, 1993 - cell.com
Recent studies have shown that a locus responsible for hereditary nonpolyposis colorectal
cancer (HNPCC) is on chromosome 2p and that tumors developing in these patients contain …

[HTML][HTML] Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations

TR Rebbeck, HT Lynch, SL Neuhausen… - … England Journal of …, 2002 - Mass Medical Soc
Background Data concerning the efficacy of bilateral prophylactic oophorectomy for
reducing the risk of gynecologic cancer in women with BRCA1 or BRCA2 mutations are …

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

SM Domchek, TM Friebel, CF Singer, DG Evans… - Jama, 2010 - jamanetwork.com
Context Mastectomy and salpingo-oophorectomy are widely used by carriers of BRCA1 or
BRCA2 mutations to reduce their risks of breast and ovarian cancer. Objective To estimate …

New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC

HFA Vasen, P Watson, JP Mecklin, HT Lynch - Gastroenterology, 1999 - Elsevier
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome)
proposed by the International Collaborative Group on HNPCC - ScienceDirect Skip to main …

[PDF][PDF] Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

TR Rebbeck, T Friebel, HT Lynch… - Journal of clinical …, 2004 - seom.org
Purpose Data on the efficacy of bilateral prophylactic mastectomy for breast cancer risk
reduction in women with BRCA1 and BRCA2 (BRCA1/2) mutations are limited, despite the …

Mutation of a mutL Homolog in Hereditary Colon Cancer

N Papadopoulos, NC Nicolaides, YF Wei, SM Ruben… - Science, 1994 - science.org
Some cases of hereditary nonpolyposis colorectal cancer (HNPCC) are due to alterations in
a mutS-related mismatch repair gene. A search of a large database of expressed sequence …